Open for input: AI in Healthcare 2019 Leadership Survey

Dave Pearson | | Health Exec | Economics
AI

Seeking to gather and share data on the state of AI in healthcare, AI in Healthcare has opened its inaugural leadership survey. Questions cover how healthcare organizations are paying for AI, whether they’re buying or building their AI-enabled solutions, where AI’s potential is already being realized—and more.

The survey is designed to take no more than 10 minutes to complete, according to AI in Healthcare Chief Content Officer Mary Tierney. Published responses will be aggregated and anonymized.

To encourage participation, AI in Healthcare is entering respondents in a drawing to win one of 50 Amazon gift cards, each valued at $50. The publication also will send each respondent an executive summary of the results once all are in.

To take the survey, click here now.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Cardiologist sues health system over gender discrimination, unequal pay and hostile treatment
FTC, DOJ and HHS release report warning of private equity consolidation in healthcare
Q&A: Vulnerable patients hit hardest by anesthesia reimbursement cuts
Momentum continues for renal denervation as CMS considers national Medicare coverage
Johnson & Johnson buys depression drug and its manufacturer for $15B
UnitedHealth, Amedisys ask federal judge to dismiss DOJ lawsuit blocking $3.3B merger

Around the web

AI in Healthcare
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.